Skip to main content
Home / News and Insights / News / BDB Pitmans advises on Verici Dx plc IPO
11 November 2020

BDB Pitmans advises on Verici Dx plc IPO

The BDB Pitmans corporate team has advised on the successful admission of Verici Dx plc (‘Verici’) to trading on the London Stock Exchange AIM market. Admission occurred at 8am on 3 November 2020.

Verici is an immuno-diagnostics development company, primarily focused on kidney transplantation. Its kidney transplant assays use advanced next-generation sequencing to help define a personalised risk-profile of each patient over the course of their transplant journey, as well as to potentially detect injury in advance of clinical tests.

£14.5 million was raised through a placing, (£12 million), share subscription (£2.1 million) and restricted offer (£0.4 million).

Nick McCarthy, corporate partner at BDB Pitmans led the transaction, and was assisted by senior associate Daniel King, solicitor Laura Crotch and trainee solicitor Emma Watson.

Commenting on the transaction, partner Nick McCarthy remarks:

‘The corporate team is delighted to have advised on another successful IPO and to secure an excellent outcome for the client in this challenging climate. It is also heartening to see the company open strongly in the first day of dealings.’

Related Articles

Our Offices

London
One Bartholomew Close
London
EC1A 7BL

Cambridge
50/60 Station Road
Cambridge
CB1 2JH

Reading
The Anchorage, 34 Bridge Street
Reading RG1 2LU

Southampton
Grosvenor House, Grosvenor Square
Southampton SO15 2BE

 

Reading
The Anchorage, 34 Bridge Street
Reading RG1 2LU

Southampton
Grosvenor House, Grosvenor Square
Southampton SO15 2BE

  • Pay my invoice
  • Lexcel
  • CYBER ESSENTIALS PLUS

© BDB Pitmans 2020. One Bartholomew Close, London EC1A 7BL - T +44 (0)345 222 9222